MedTrace Logo

Cemented vs Non-cemented Semiendoprosthesis in the Treatment of Proximal Femoral Fractures

NCT00859378 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2015-04-07

No results posted yet for this study

Summary

The hip semiendoprosthesis is an acceptable method to treat the proximal femoral fractures. Traditionally, the cemented version of the semiendoprosthesis has been used for this indication. However, the cementing carries a risk of fat embolism during the pressurization of the cement. The fat embolism can be avoided when using the non-cemented semiendoprosthesis. In this study we want to find out whether there are any differences in the treatment results between the cemented and non-cemented semiendoprostheses when treating the proximal femoral fractures.

Conditions

  • Hip Fracture
  • Proximal Femoral Fracture

Interventions

DEVICE

Cemented semiendoprosthesis

Application of a cemented semiendoprosthesis (Basis, Smith \& Nephew)

DEVICE

non-cemented

Patients are treated with a non-cemented semiendoprosthesis (Biomet Taperloc, Biomet Inc.)

Sponsors & Collaborators

  • The Finnish Research Foundation for Orthopaedics and Traumatology

    collaborator UNKNOWN

  • Kuopio University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2014-12-31
Completion
2015-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00859378 on ClinicalTrials.gov